|
Q3 FY2026
As of Jun 30, 2026
|
Q2 FY2026
As of Mar 31, 2026
|
Q1 FY2026
As of Dec 31, 2025
|
Q4 FY2025
As of Sep 30, 2025
|
Q3 FY2025
As of Jun 30, 2025
|
Q2 FY2025
As of Mar 31, 2025
|
Q1 FY2025
As of Dec 31, 2024
|
Q4 FY2024
As of Sep 30, 2024
|
Q3 FY2024
As of Jun 30, 2024
|
Q2 FY2024
As of Mar 31, 2024
|
Q1 FY2024
As of Dec 31, 2023
|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jun 30, 2023
|
Q2 FY2023
As of Mar 31, 2023
|
Q1 FY2023
As of Dec 31, 2022
|
Q4 FY2022
As of Sep 30, 2022
|
Q3 FY2022
As of Jun 30, 2022
|
Q2 FY2022
As of Mar 31, 2022
|
Q1 FY2022
As of Dec 31, 2021
|
Q4 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Prepaid expenses and other receivable | ||||||||||||||||||||
| Other receivable | ||||||||||||||||||||
| Right-of-use asset, net | ||||||||||||||||||||
| Total non-current assets | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Other payable | ||||||||||||||||||||
| Lease liability | ||||||||||||||||||||
| Loan payable | ||||||||||||||||||||
| Convertible notes payable, current portion | ||||||||||||||||||||
| Due to related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total due to related party | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Loan payable | ||||||||||||||||||||
| Total non-current liabilities | ||||||||||||||||||||
| Convertible notes payable | ||||||||||||||||||||
| Lease liability | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| CONTINGENCIES AND COMMITMENTS | ||||||||||||||||||||
| Stockholders’ Deficit | ||||||||||||||||||||
| Common stock: 75,000,000 shares authorized; $0.001 par value 17,225,716 and 13,297,143 shares issued and outstanding at June 30, 2026 and September 30, 2025, respectively | ||||||||||||||||||||
| Additional Paid-in Capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders’ Deficit | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||||||||||||||||||||
Loading...
